Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AD4D
|
|||
| Former ID |
DNCL001881
|
|||
| Drug Name |
CXL-1020
|
|||
| Indication | Acute decompensated heart failure [ICD-11: BD1Z; ICD-10: I50, I50.9; ICD-9: 428] | Phase 2 | [1] | |
| Company |
Cardioxyl Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H9NO5S2
|
|||
| Canonical SMILES |
CS(=O)(=O)C1=CC=CC=C1S(=O)(=O)NO
|
|||
| InChI |
1S/C7H9NO5S2/c1-14(10,11)6-4-2-3-5-7(6)15(12,13)8-9/h2-5,8-9H,1H3
|
|||
| InChIKey |
RZRWBKKAFHXNEQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 950834-06-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01096043) A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.